What's new in IDIS/Web:

 • New Drugs

 • Drug Name/Code Changes

 • FDA Approval Packages

 • Advisory Committee Meetings

 • Priority Clinical Practice Guidelines

 • Continuing Education Articles

 

 

IDIS Training Tools

 

Stay Connected:

 • IDIS on Facebook

 • Join Our Update Lists

 • CAMIPR

 • Monthly Update Information

 

 

Email: idis@uiowa.edu


Drug Information Resources

IDIS Logo   IDIS Monthly Update Information - December 2011

NEW DRUG TERM
AMIFAMPRIDINE
AR-12286
AS-1402
ASPARAGINASE ERWINIA CHRYS
BAVITUXIMAB
CARROT OIL
ERIBAXABAN
EVACETRAPIB
HIV HYPERIMMUNE GLOBULIN
INDOLE-3-ACETIC ACID
JNJ-38431055
MACITENTAN
MONOHER
PF-04929113
RG-7160
SB-939
TASQUINIMOD
XEN-D-0501

CODE
12040035
52360028
10120292
10121004
10120293
92510282
20120481
24060055
80040053
10120415
68200028
24120109
92404012
10121002
10120294
10121005
10121003
28081269


DRUG NAME/CODE CHANGES

OLD TERM & CODENEW TERM & CODE
MEDI-545 82000536SIFALIMUMAB 82000536


FDA APPROVAL PACKAGES

Article Numbers 667713-667726: Clobazam, Onfi. FDA Approval Package for NDA 202067. FDA Approval Package 2011.


ADVISORY COMMITTEE MEETINGS

Article Numbers 667745-667750: Endocrinologic and Metabolic Drugs Advisory Committee Meeting, November 2, 2011. FDA Advisory Committee 2011.

Article Numbers 667740-667744: Pediatric Subcommittee of the Oncologic Drugs Advisory Committee Meeting, November 2, 2011. FDA Advisory Committee 2011.

Article Numbers 667734-667739: Gastrointestinal Drugs Advisory Committee Meeting, November 16, 2011. FDA Advisory Committee 2011.

Article Numbers 667727-667733: Gastrointestinal Drugs Advisory Committee Meeting, November 17, 2011. FDA Advisory Committee 2011.


PRIORITY CLINICAL PRACTICE GUIDELINES

Article Number 667358: Tendera M, Aboyans V, Bartelink M L, Baumgartner I, et al. ESC Guidelines on the Diagnosis and Treatment of Peripheral Artery Diseases: Document Covering Atherosclerotic Disease of Extracranial Carotid and Vertebral, Mesenteric, Renal, Upper & Lower Extremity Arteries (Ref Art 667350). Eur Heart J 2011, 32:2851-2906.


CONTINUING EDUCATION ARTICLES

Article Number 667886: Anonymous. Vasopressors and Inotropes (0.1 CEU) [IDIS Note: The 1.0 Hour of CE Credit is for These Articles in this Issue, Article Numbers 667884-667886]. Med Lett Drugs Ther 2011, 53:90-92.

Article Number 667885: Anonymous. Tadalafil (Cialis) for Signs and Symptoms of Benign Prostatic Hyperplasia (0.1 CEU) [IDIS Note: The 1.0 Hour of CE Credit is for These Articles in this Issue, Article Numbers 667884-667886]. Med Lett Drugs Ther 2011, 53:89-90.

Article Number 667884: Anonymous. Sitagliptin and Simvastatin (Juvisync) (0.1 CEU) [IDIS Note: The 1.0 Hour of CE Credit is for These Articles in this Issue, Article Numbers 667884-667886]. Med Lett Drugs Ther 2011, 53:89.

Article Number 667882: Anonymous. Drugs for Ovulation Induction (0.1 CEU) [IDIS Note: The 1.0 Hour of CE Credit is for These Articles in this Issue, Article Numbers 667881 and 667882]. Med Lett Drugs Ther 2011, 53:86-88.

Article Number 667557: Cada D J, Levien T L, Baker D E. Fidaxomicin (0.15 CEU). Hosp Pharm 2011, 46:884-890.

Article Number 666750: Anonymous. Drugs for Postmenopausal Osteoporosis (0.2 CEU). Treat Guidel Med Lett 2011, 9:67-74.


College of Pharmacy